OpenHealth Q&A

Get answered by medical professionals

Advice Needed: Persistent UTI Challenges

4/3/2025, 7:50:36 AMMale25-34

Hello everyone! I’ll strive to be brief, but given the complexity of my situation, there’s quite a bit of detail to cover, and I appreciate your patience with this lengthy message. **Patient Profile:** - Age: 20, female - Current Medications/Supplements: Norethindrone, Olly vaginal probiotics, Metoprolol tartrate, Metoprolol succinate XR, Midodrine (twice daily) - Diagnoses: Irregular periods since 2021, POTS (diagnosed 2024), hypermobile Ehlers-Danlos syndrome (2024) **Key History:** Multiple stool diaries and daily laxative use have ruled out bowel-related problems. Cystoscopy examinations confirmed normal anatomy without the presence of fistulas. There is no known family history of bladder issues. I ensure to drink sufficient fluids, maintain hygiene practices (steering clear of bubble baths, proper wiping techniques, etc.), and have experimented with various probiotics and dietary modifications to address food-related factors. I typically urinate every 1.5 to 2 hours, though I have consistently needed to exert effort to fully empty my bladder. I only became sexually active in 2024, and I practice safe sex. **Tests Completed:** Cystograms, cystoscopies, urodynamics, VCUGs (voiding cystourethrograms), ultrasounds, CT scans (with and without contrast), DMSA scans, MRIs, and blood tests. **Antibiotic History:** I’ve taken various antibiotics including Bactrim, Augmentin/amoxicillin, Fosfomycin, nitrofurantoin (both Macrodantin and Macrobid), Keflex, fluoroquinolones (Cipro and Levaquin), Rocephin, and Doxycycline. Strong intravenous antibiotics like Vabomere, Recarbrio, and Fetroja have not been utilized due to age restrictions during earlier years. At just six months old, I suffered significant kidney infections related to recurrent urinary tract infections (UTIs), resulting in a diagnosis of vesicoureteral reflux. A Deflux procedure was performed but provided only temporary relief. I later faced issues of incontinence and an overactive bladder, and treatments such as long-term Ditropan and flaxseed oil yielded no improvements. Additional investigations highlighted urine retention and dysfunctional voiding, prompting the initiation of biofeedback therapy, cranberry supplements, and daily Kegel exercises. Although these methods aided in urination, the UTIs persisted, eventually leading to scarring that affected half of my left kidney. In 2012, a successful bilateral ureteral reimplantation procedure halted further kidney infections and damage, yet I continued to suffer from UTIs. I’ve consulted numerous specialists, including urologists, infectious disease experts, internal medicine doctors, gynecologists, and gastroenterologists. Prophylactic antibiotic regimens from 2005 to 2015 resulted in the emergence of multidrug-resistant infections, prompting a strategy to minimize antibiotic use unless absolutely essential. Antibiotics no longer effectively eliminate the infection and are instead used to alleviate symptoms. I’ve also attempted pelvic floor therapy, Hipprex, and D-Mannose with no success; in fact, Hipprex seemed to exacerbate my symptoms, and the pelvic floor therapy indicated no weakness in my bladder. A trial of the InterStim device in 2020 brought no improvements. Bladder scans have confirmed that I completely void, ruling out urine retention or dysfunctional voiding. A vaginal ultrasound indicated thickening of the bladder wall linked to chronic colonization. In 2022, I faced hospitalization due to a severe UTI, which resulted in brief urine retention and grade 2 hydronephrosis of my left kidney. A VCUG confirmed there was no reflux, and tests for diabetes, thyroid dysfunction, and autoimmune diseases returned negative results. An MRI also excluded multiple sclerosis as a possible factor. By 2024, I had consultations with both a urologist and a urological reconstruction expert at the Cleveland Clinic, but they were unable to offer substantial guidance. Although the UTI vaccine from the UK was considered, it was perceived as preventative rather than curative, thus unlikely to aid my situation. The urologists have concurred that options like bladder ablation and antibiotic flushes would only provide short-term relief, if any. Furthermore, I am reluctant to undergo urethral catheterization due to traumatic experiences from past procedures; my urologist also supports that catheterization may not be beneficial and could introduce further bacterial complications. After consulting nearly fifteen medical professionals, I find myself in a state of confusion regarding the ongoing issue with this entrenched UTI. I am contemplating bladder excision and an Indiana Pouch diversion, yet the Cleveland Clinic specialists have declined to perform the surgery. What options do I have moving forward?

Crohn's DiseaseInternal MedicineRheumatology

Answers (1)

Cony

4/3/2025, 7:50:56 AM

OpenHealth AI

It sounds like you’ve been through an incredibly challenging period with persistent UTIs and have explored an extensive range of medical options without finding adequate relief. Your history of complex urinary issues, along with the various treatments you have undergone, highlights the need for a tailored approach as you move forward.

Main Points:

  1. Explore non-antibiotic management strategies.
  2. Continue to engage with specialists while considering further treatment options.
  3. Focus on symptom management and lifestyle adjustments that could provide relief.

Explanation:

Given your extensive history and the challenges with recurrent UTIs resistant to antibiotic treatment, it is essential to focus on alternative strategies that can help reduce the frequency and severity of your symptoms. Factors such as bladder health, urine composition, and lifestyle choices could play significant roles in managing your situation.

Prioritized Next Steps:

  1. Dietary and Lifestyle Adjustments:

    • Hydration: Continue staying well-hydrated, as it helps dilute urine and may reduce irritation.
    • Dietary Changes: Consider reducing irritants, such as caffeine, alcohol, and spicy foods, which can exacerbate bladder symptoms.
    • Probiotic Use: Since you are already using vaginal probiotics, consider discussing the addition of certain oral probiotics that are specifically designed for urinary health.
  2. Symptom Tracking:

    • Keep a detailed symptom diary documenting UTI symptoms, frequency, and any potential triggers. This can be invaluable when consulting with healthcare providers.
  3. Exploring Novel Treatments:

    • Intravesical Therapy: Investigate options like instilling medications directly into the bladder, which has been shown to provide relief for some patients.
    • Local Therapies: Discuss novel treatments such as the use of bladder instills (e.g., Hyaluronic Acid) as they may help with bladder lining health.
  4. Consultation with Specialists:

    • Seek out a multidisciplinary team, including a urologist with expertise in complex urinary conditions, a gynecologist familiar with urinary symptoms, and possibly a pain management specialist. This collaborative approach might uncover new avenues of treatment.
  5. Consider Non-Surgical Options:

    • While bladder excision is a significant step and may not be advisable given prior consultations, discuss alternative surgical options or advanced interventions, such as a bladder augmentation, which can increase bladder capacity without removing it.
  6. Psychosocial Support:

    • Given the emotional toll that chronic conditions can take, it may be helpful to connect with a counselor or support group that focuses on chronic illness. This can provide additional coping strategies and emotional support.

Reassurance:

It’s completely understandable to feel overwhelmed after navigating so many medical opinions and treatments. Remember that you’re not alone in this, and finding a management strategy that works for you may take time and persistence. Continue advocating for your health, and don’t hesitate to reach out for support throughout this process.

Related Questions

Understanding Atrial Fibrillation and Thyroid Issues: Variability in Cardioversion Decisions

Hello everyone, I’m reaching out for guidance regarding my mother’s current health situation, and I’d greatly appreciate any shared experiences or thoughts. **My mother's background:** - **Age**: 55 years - **Weight**: Recently dropped to 116 kg from 118 kg in just two days, likely due to diuretics. - **Health history**: Previously an underactive thyroid, undiagnosed and untreated, now presenting as overactive. - **Medications**: Currently taking thyroid medication and a beta-blocker (Rapiblock). **Current health status:** My mother has been hospitalized since Tuesday, experiencing **atrial fibrillation with heart rates exceeding 200** beats per minute due to her thyroid's hyperactivity. - The plan for cardioversion was initially settled on Tuesday. However, the following day, the medical team advised postponing it until her thyroid levels could be stabilized, believing that her heart rate would return to normal once her thyroid condition was managed. - Her **obesity** precludes her from undergoing a transthoracic echocardiogram, and due to her thyroid concerns, she cannot handle contrast dye (this has been a consistent issue for over four years). Therefore, the only feasible option was a **transesophageal echocardiogram (TEE)**, which has yet to be performed. - She has been prescribed various medications including beta-blockers and thyroid treatments in the past. - On Friday, a doctor proposed proceeding with cardioversion; however, the attending senior physician objected. - Today (Saturday), another clinician has expressed a desire to move forward with cardioversion, having initiated a new medication, as the senior physician is unavailable. - **Communication has been unclear**, as we were notified of developments by a nurse rather than the physician in charge, causing confusion and anxiety. - Currently, only a **chest X-ray** is scheduled, and the TEE remains unaddressed. **My inquiries are as follows:** 1. Is it common for medical professionals to have varying opinions and frequently revise medication or treatment plans like cardioversion? 2. Is it safe to conduct cardioversion in the absence of a TEE? I presumed that this was a standard procedure to exclude the presence of blood clots. 3. Is it usual practice to have only a chest X-ray prior to moving ahead with cardioversion? 4. How typical is it for patients or their families to not be directly informed about treatment changes and learn about them through nursing staff instead? I recognize that this cannot substitute for professional medical advice. I’m simply trying to discern whether these circumstances are typical or if we should express our concerns more assertively with the healthcare facility. Thank you for your insights!

Thyroid DisordersEndocrinologyRheumatology
Male25-34
43 minutes ago

28-Year-Old Male Experiencing Scalp Sensations Post-Amitriptyline Treatment

I am a 28-year-old man in generally good health, without any cardiac concerns. Approximately a month ago, I encountered intense pain localized to one side of my head, which was unresponsive to paracetamol. However, a single dose of a migraine treatment provided substantial relief. Following that, I began a regimen of amitriptyline, starting at a nightly dose of 10 to 25 mg. While my head pain has diminished significantly—by about 90 to 95%—I now experience occasional uncomfortable sensations on my scalp. These feelings include pins and needles, a cooling sensation, and some crawling feelings near my hairline and ears. There are fleeting moments where I feel brief throbs lasting a second, but I do not have any persistent headaches. To clarify, I do not experience any of the following: - Nausea - Weakness in my limbs - Numbness - Changes in my vision - Coordination difficulties - Seizures The symptoms I have are transient, shifting around and often intensifying when I become conscious of them or as the day progresses. I would like to know: Is it common to experience these sensations during the recovery stage following episodes of neuralgia or migraine-like discomfort? Additionally, could the amitriptyline potentially be causing these temporary paresthetic sensations? I am seeking some reassurance or advice on what is typically observed during this healing process. Thank you.

Multiple SclerosisCrohn's DiseaseEndocrinology
Male25-34
1 hour ago

Concerns About My Toes

Age: 30, Female Currently, I am on the lookout for a reputable podiatrist in my vicinity. However, I've encountered a perplexing issue with my foot. Just last night, I noticed a growth on the side of my toe, something entirely new to me. I maintain a nutritious diet and have a demanding job that requires me to be on my feet quite often. My footwear includes brands such as Brooks Ghost Runners, Hoka Bondi 9’s, and Nike Motiva’s, and I don’t opt for restrictive socks. I also apply Vick’s Vaporub to my feet, a practice handed down from my family, and stick with simple, non-fragrant lotions like Vanicream and CeraVe SA Cream for my skin. In addition, I am curious about the my big toenail's change in color. What might be the underlying reasons for this? Also, I have these persistent dark spots on my toes that I've struggled with since my days on the runway. Despite my efforts, nothing has succeeded in lightening or diminishing their appearance. I'm just looking to determine if there might have been a factor from the past that could have contributed to these issues. I’m not sure what else to include, but I’m open to answering any questions you might have. Thank you for your attention! Best wishes from a worried soul!

ArthritisFibromyalgiaInternal Medicine
Male25-34
2 hours ago

7-Month-Old Child with Abernethy Malformation - Exploring Treatment Options

# 7-Month-Old Child with Abernethy Malformation - Exploring Treatment Options ## [7-Month-Old] Identified with Abernethy Malformation (Congenital Portosystemic Shunt) - Treatment Methods? **Age:** 7 months **Gender:** Female **Height:** Age-appropriate **Weight:** Currently 9 kg, was 2.8 kg at birth **Ethnicity:** Asian **Duration of Symptoms:** Present since birth **Location:** Uzbekistan **Pre-existing Health Issues:** Abernethy malformation (congenital portosystemic shunt), liver hemangiomas, chronic jaundice, anemia **Current Treatments:** Supportive management --- ## INITIAL PRESENTATION (June 2025 - July 2025) Our daughter arrived on **June 27, 2025**, presenting with: - Birth weight: **2.8 kg** - Marked jaundice (yellowing of skin and sclera) - Pale or clay-colored stools - **Bilirubin level: 245 μmol/L** (typically <20) An immediate ultrasound indicated multiple liver anomalies, initially thought to be hemangiomas. --- ## FIRST COMPREHENSIVE ASSESSMENT (August 1, 2025 - 1 Month Old) ### Multislice Computed Tomography (MSCT) with 3-Phase Contrast (August 1, 2025): **RESULTS:** - **Portocaval shunt size: 9.9 mm** (blood bypassing the liver into the inferior vena cava) - **Arteriovenous shunt size: 4.4 mm** - **Portal vein size: 6.1 mm** (patent) - **Three nodular cystic lesions** located in the perivascular area, with largest measuring 11.6×20.7 mm, enhancing during the venous phase - Liver features a heterogeneous architecture, exhibiting irregular enhancement - Gallbladder appears elongated and slightly enlarged - Other abdominal organs exhibit normal findings **RADIOLOGIST’S ASSESSMENT:** "Congenital portosystemic shunt indicative of Abernethy malformation; less likely arteriovenous malformation (AVM); cannot dismiss the possibility of localized liver lesions." **ADVICE:** Seek consultations with an abdominal and vascular surgeon. ### Blood Tests (August 1, 2025): **Complete Blood Count:** - WBC: 10.44 × 10⁹/L (normal range) - **RBC: 2.1 × 10¹²/L** (LOW - indicating severe anemia) - **Hemoglobin: 69 g/L** (CRITICALLY LOW; normal is 117-166) - Platelets: 403 × 10⁹/L (elevated) **Biochemistry Analysis:** - Urea: 1.80 mmol/L (normal) - Creatinine: 33.4 μmol/L (normal) - **ALT: >1000 IU/mL** (EXTREMELY HIGH - severe liver dysfunction) --- ## FOLLOW-UP IMAGING (December 16, 2025 - 5.5 Months Old) ### Liver Ultrasound: **RESULTS:** - Right lobe: 64 mm, left lobe: 43 mm - Liver capsule appears irregular and vague - **Parenchyma: heterogeneous, showing 7 hypo-isoechoic nodules** (sizes range from 11.5×10.7 mm to 17.6×15.4 mm) - Capsule features uneven contours - Blood flow noted during Doppler examination - No dilation in intrahepatic bile ducts - **Portal vein: 3.9 mm** (decreased from 6.1 mm - indicating improvement) - Common bile duct: 1.4 mm - Gallbladder: measures 43.7×9.2 mm (pear-shaped, wall thickness 2.0 mm, homogeneous, free of stones) **ULTRASOUND ASSESSMENT:** "Presence of liver volumetric formations (specifically liver hemangiomas)." --- ## LATEST MSCT (February 6, 2026 - 7 Months Old) ### MSCT with 3-Phase Contrast: **FINDINGS:** - Liver remains normal in size, but shows heterogeneous structure with uneven contrast enhancement - **Portocaval shunt: 9.9 mm** (no change, continues to drain directly into the inferior vena cava avoiding liver acinus) - **Arteriovenous shunt: 4.4 mm** (no alteration) - **Three nodular cystic lesions** in perivascular space, maximum size 11.6×20.7 mm, enhancing in the venous phase - **Portal vein: 6.1 mm** (noted during porto-venous phase) - Arteries show no filling abnormalities - Intrahepatic bile ducts remain non-dilated - Gallbladder is elongated and slightly bigger, free from stones - Pancreas: normal - Spleen: measures 66.9×38.5 mm (not enlarged), splenic vein is 3.6 mm - Kidneys: normal placements and structure - No excess fluid detected in the abdominal cavity - No visible changes in lymph nodes **MSCT ANALYSIS:** "Congenital portosystemic shunt indicative of Abernethy malformation, unlikely to be AVM, presence of focal liver lesions cannot be ruled out." **RECOMMENDATION:** Engage with an abdominal and vascular surgeon. --- ## RECENT BLOOD WORK (December 2025 - January 2026) ### Complete Blood Count (January 19, 2026): - WBC: 5.8 × 10⁹/L (SHOWS IMPROVEMENT) - **RBC: 2.93 × 10¹²/L** (IMPROVED but still low) - **Hemoglobin: 72 g/L** (SHOWS IMPROVEMENT but still low) - Platelets: 223 × 10⁹/L (BACK TO NORMAL) - Neutrophils: 30.0% - Lymphocytes: 64.8% - Monocytes: 4.6% ### Biochemistry (January 28, 2026): - Total protein level: 67 g/L (slightly deficient) - Creatinine: 20.7 μmol/L - **Total Bilirubin: 242 μmol/L** (STILL HIGH - unchanged) - **Direct Bilirubin: 142 μmol/L** (VERY HIGH) - **ALT: 50 IU/mL** (DRASTICALLY LOWER from >1000!) --- ## OVERVIEW OF PROGRESS OVER 6 MONTHS | Parameter | August 2025 | January 2026 | Change | |------------------|-------------|---------------|--------------------------| | **Hemoglobin** | 69 g/L | 72 g/L | ↗ Slight improvement | | **RBC** | 2.1 | 2.93 | ↗ Improved | | **ALT** | >1000 | 50 | ✓✓ MAJOR IMPROVEMENT | | **Bilirubin** | 245 | 242 | → Unchanged (still elevated) | | **Portal vein** | 6.1 mm | 3.9 mm (US) | ↗ Decreased | | **Platelets** | 403 | 223 | ↘ Normalized | | **Shunt size** | 9.9 mm | 9.9 mm | → No Change | --- ## CURRENT SITUATION (February 2026 - 7 Months Old) - **Weight:** 9 kg (good growth rate in spite of condition) - **Jaundice:** Continues to be present (yellow skin) - **Stools:** Remain pale/clay-colored - **Development:** Achieving appropriate milestones - **Energy:** Appears to have a good energy level - **Feeding:** Normal appetite --- ## QUESTIONS FOR r/AskDocs We have been informed this is **Type 2 Abernethy malformation** (portal vein present). **Three treatment avenues have been proposed:** ### Option 1: **Endovascular Coil Embolization** (minimally invasive approach) - A catheter is inserted via the leg vein to access the shunt and deploy coils/plugs to close the abnormal vessels - Pros: No surgical incision, minimal discomfort, short hospital stay (2-4 days), no scars, enhanced safety - Duration: 1-2 hours - Recovery: 2-4 weeks for jaundice to show improvement ### Option 2: **Open Surgical Intervention** - An incision in the abdomen to ligate abnormal vessels and redirect blood to the liver - Pros: Direct visualization, effective results - Cons: Surgical scar, longer recovery time (7-14 days in hospital) - Duration: 2-4 hours ### Option 3: **Liver Transplantation** - We have been advised this is not necessary as the portal vein is functional and liver health is improving. --- ## SPECIFIC QUESTIONS TO CONSIDER: 1. **With a functional portal vein (6.1 mm) and improving liver function (ALT normalized), is it advisable to pursue endovascular closure as the preferred treatment?** 2. **Despite ALT levels improving, the bilirubin remains consistently high (242). Should this be a cause for concern? Is there a prospect for it to normalize post shunt closure?** 3. **Are the hemangiomas/nodules (11.6×20.7 mm) linked to the shunt? Will they likely resolve following shunt repair?** 4. **How urgent is the proposed intervention? Is immediate action required, or is there flexibility to wait a few months?** 5. **What complications should we be vigilant for during the waiting period?** 6. **Regarding endovascular closure - what is the average success rate for infants aged 7 months? Are there concerns regarding the shunt size (9.9 mm)?** 7. **The measurement of the portal vein has shown improvement from 6.1 mm to 3.9 mm; should this be perceived as a positive sign or a reason for concern?** 8. **Are there special directives (diet modifications, medications) we should consider while awaiting the procedure?** 9. **Post-procedure, how long should we expect it might take for:** - Normalization of bilirubin levels? - Return of stool color to normal? - Resolution of jaundice? - Regression of hemangiomas? 10. **Can you recommend any specialized centers for pediatric Abernethy malformation treatments? We are located in Uzbekistan but are prepared to travel (to Turkey, Russia, South Korea, etc.)** --- ## ADDITIONAL INFORMATION - No family history of hepatic diseases - Pregnancy and delivery were normal - No additional congenital defects identified - Immunizations up to date - No history of bleeding disorders - No signs indicative of encephalopathy - Child is alert and engaged --- **I can supply actual MSCT images and comprehensive lab reports if they would be of assistance.** We sincerely appreciate any insights you can provide. We are striving to make the most informed decision regarding our daughter’s care and highly value expert medical opinions. **TL;DR:** 7-month-old diagnosed with Abernethy Type 2 malformation (9.9 mm portocaval shunt, patent portal vein). Liver functionality is improving (normalized ALT) while bilirubin remains elevated (242). Evaluating options between endovascular coil embolization and open surgery. Seeking expert advice on optimal treatment strategy and timing.

Thyroid DisordersInternal MedicineEndocrinology
Male25-34
2 hours ago

Strange Jelly-Like Substance Observed from Wound

I’m a 21-year-old female living with an auto-inflammatory condition known as hidradenitis suppurativa (HS). Recently, I've experienced a concerning issue with one of my wounds. This particular wound causes significant pain and excessive bleeding. However, whenever I attend to it, I tend to find this unusual jelly-like substance present within it. Interestingly, this phenomenon has only occurred with this one wound and not any of the others I have. The bleeding seems to persist until I manage to remove this jelly substance, after which it typically slows down and comes to a halt completely. I’m seeking insights into what this might signify so that I can effectively discuss it with my healthcare provider.

ArthritisFibromyalgiaInternal Medicine
Male25-34
4 hours ago